These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9504324)

  • 1. Screening for mutations in the neuropeptide Y Y5 receptor gene in cohorts belonging to different weight extremes.
    Rosenkranz K; Hinney A; Ziegler A; von Prittwitz S; Barth N; Roth H; Mayer H; Siegfried W; Lehmkuhl G; Poustka F; Schmidt M; Schäfer H; Remschmidt H; Hebebrand J
    Int J Obes Relat Metab Disord; 1998 Feb; 22(2):157-63. PubMed ID: 9504324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic studies of neuropeptide Y and neuropeptide Y receptors Y1 and Y5 regions in morbid obesity.
    Roche C; Boutin P; Dina C; Gyapay G; Basdevant A; Hager J; Guy-Grand B; Clément K; Froguel P
    Diabetologia; 1997 Jun; 40(6):671-5. PubMed ID: 9222646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. No evidence for involvement of the leptin gene in anorexia nervosa, bulimia nervosa, underweight or early onset extreme obesity: identification of two novel mutations in the coding sequence and a novel polymorphism in the leptin gene linked upstream region.
    Hinney A; Bornscheuer A; Depenbusch M; Mierke B; Tölle A; Middeke K; Ziegler A; Roth H; Gerber G; Zamzow K; Ballauff A; Hamann A; Mayer H; Siegfried W; Lehmkuhl G; Poustka F; Schmidt MH; Hermann H; Herpertz-Dahlmann BM; Fichter M; Remschmidt H; Hebebrand J
    Mol Psychiatry; 1998 Nov; 3(6):539-43. PubMed ID: 9857981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic mutation screening of the pro-opiomelanocortin gene: identification of several genetic variants including three different insertions, one nonsense and two missense point mutations in probands of different weight extremes.
    Hinney A; Becker I; Heibült O; Nottebom K; Schmidt A; Ziegler A; Mayer H; Siegfried W; Blum WF; Remschmidt H; Hebebrand J
    J Clin Endocrinol Metab; 1998 Oct; 83(10):3737-41. PubMed ID: 9768693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beta 3-adrenergic-receptor allele distributions in children, adolescents and young adults with obesity, underweight or anorexia nervosa.
    Hinney A; Lentes KU; Rosenkranz K; Barth N; Roth H; Ziegler A; Hennighausen K; Coners H; Wurmser H; Jacob K; Römer G; Winnikes U; Mayer H; Herzog W; Lehmkuhl G; Poustka F; Schmidt MH; Blum WF; Pirke KM; Schäfer H; Grzeschik KH; Remschmidt H; Hebebrand J
    Int J Obes Relat Metab Disord; 1997 Mar; 21(3):224-30. PubMed ID: 9080262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel polymorphisms in the neuropeptide-Y Y5 receptor associated with obesity in Pima Indians.
    Jenkinson CP; Cray K; Walder K; Herzog H; Hanson ; Ravussin E
    Int J Obes Relat Metab Disord; 2000 May; 24(5):580-4. PubMed ID: 10849579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of the Y1 receptor in the regulation of neuropeptide Y-mediated feeding: comparison of wild-type, Y1 receptor-deficient, and Y5 receptor-deficient mice.
    Kanatani A; Mashiko S; Murai N; Sugimoto N; Ito J; Fukuroda T; Fukami T; Morin N; MacNeil DJ; Van der Ploeg LH; Saga Y; Nishimura S; Ihara M
    Endocrinology; 2000 Mar; 141(3):1011-6. PubMed ID: 10698177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular cloning, organization and localization of the gene for the mouse neuropeptide Y-Y5 receptor.
    Nakamura M; Yokoyama M; Watanabe H; Matsumoto T
    Biochim Biophys Acta; 1997 Sep; 1328(2):83-9. PubMed ID: 9315606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No evidence for involvement of polymorphisms of the dopamine D4 receptor gene in anorexia nervosa, underweight, and obesity.
    Hinney A; Schneider J; Ziegler A; Lehmkuhl G; Poustka F; Schmidt MH; Mayer H; Siegfried W; Remschmidt H; Hebebrand J
    Am J Med Genet; 1999 Dec; 88(6):594-7. PubMed ID: 10581473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel neuropeptide Y1 and Y5 receptor gene variants: associations with serum triglyceride and high-density lipoprotein cholesterol levels.
    Blumenthal JB; Andersen RE; Mitchell BD; Seibert MJ; Yang H; Herzog H; Beamer BA; Franckowiak SC; Walston JD
    Clin Genet; 2002 Sep; 62(3):196-202. PubMed ID: 12220433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of food intake by neuropeptide Y Y5 receptor antisense oligodeoxynucleotides.
    Schaffhauser AO; Stricker-Krongrad A; Brunner L; Cumin F; Gerald C; Whitebread S; Criscione L; Hofbauer KG
    Diabetes; 1997 Nov; 46(11):1792-8. PubMed ID: 9356028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Several mutations in the melanocortin-4 receptor gene including a nonsense and a frameshift mutation associated with dominantly inherited obesity in humans.
    Hinney A; Schmidt A; Nottebom K; Heibült O; Becker I; Ziegler A; Gerber G; Sina M; Görg T; Mayer H; Siegfried W; Fichter M; Remschmidt H; Hebebrand J
    J Clin Endocrinol Metab; 1999 Apr; 84(4):1483-6. PubMed ID: 10199800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overlapping gene structure of the human neuropeptide Y receptor subtypes Y1 and Y5 suggests coordinate transcriptional regulation.
    Herzog H; Darby K; Ball H; Hort Y; Beck-Sickinger A; Shine J
    Genomics; 1997 May; 41(3):315-9. PubMed ID: 9169127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional interaction between neuropeptide Y receptors and modulation of calcium channels in the rat hippocampus.
    Silva AP; Carvalho AP; Carvalho CM; Malva JO
    Neuropharmacology; 2003 Feb; 44(2):282-92. PubMed ID: 12623227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cloning and characterization of the guinea pig neuropeptide Y receptor Y5.
    Lundell I; Eriksson H; Marklund U; Larhammar D
    Peptides; 2001 Mar; 22(3):357-63. PubMed ID: 11287090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No evidence for an involvement of alleles of polymorphisms in the serotonin1Dbeta and 7 receptor genes in obesity, underweight or anorexia nervosa.
    Hinney A; Herrmann H; Löhr T; Rosenkranz K; Ziegler A; Lehmkuhl G; Poustka F; Schmidt MH; Mayer H; Siegfried W; Remschmidt H; Hebebrand J
    Int J Obes Relat Metab Disord; 1999 Jul; 23(7):760-3. PubMed ID: 10454111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropeptide Y1 and Y5 receptors mediate the effects of neuropeptide Y on the hypothalamic-pituitary-thyroid axis.
    Fekete C; Sarkar S; Rand WM; Harney JW; Emerson CH; Bianco AC; Beck-Sickinger A; Lechan RM
    Endocrinology; 2002 Dec; 143(12):4513-9. PubMed ID: 12446577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regionally-selective down-regulation of NPY receptor subtypes in the obese Zucker rat. Relationship to the Y5 'feeding' receptor.
    Widdowson PS
    Brain Res; 1997 May; 758(1-2):17-25. PubMed ID: 9203528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromosome 4q31-34 panic disorder risk locus: association of neuropeptide Y Y5 receptor variants.
    Domschke K; Hohoff C; Jacob C; Maier W; Fritze J; Bandelow B; Krakowitzky P; Kästner F; Rothermundt M; Arolt V; Deckert J
    Am J Med Genet B Neuropsychiatr Genet; 2008 Jun; 147B(4):510-6. PubMed ID: 17948870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extensive alternative splicing in the 5'-untranslated region of the rat and human neuropeptide Y Y5 receptor genes regulates receptor expression.
    Parker EM; Xia L
    J Neurochem; 1999 Sep; 73(3):913-20. PubMed ID: 10461880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.